Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017
  • Published Date:
    November 17 2019
  • Source:
    Emerg Infect Dis. 25(11):2159-2160
  • Language:
    English
Filetype[PDF-786.02 KB]


No Related Documents.
You May Also Like:
  1. Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017
    Personal Author:
    Martens, Liesbeth; Kuster, Sharon; de Vos, Wilco; Kersten, Maikel; Berkhout, Hanneke; Hagen, Ferry;
    Published Date:
    Jul 2019
    Source:
    Emerg Infect Dis. 25(7):1297-1303
    Description:
    Mycoplasma genitalium infections of the urogenital tract are usually treated with azithromycin; however, for the past several years, rates of azithromycin treatment failure have increased. To document the occurrence and frequency of macrolide resista...
    File Type:
    Filetype[PDF - 6.85 MB]
  2. Achromobacter xylosoxidans Infections after Prostate Biopsies, France, 2014
    Personal Author:
    Amoureux, Lucie; Bador, Julien; Neuwirth, Catherine;
    Published Date:
    November 2019
    Source:
    Emerg Infect Dis. 25(11):2158-2159
    File Type:
    Filetype[PDF - 344.39 KB]
  3. Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
    Personal Author:
    Murray, Gerald L.; Bradshaw, Catriona S.; Bissessor, Melanie; Danielewski, Jennifer; Garland, Suzanne M.; Jensen, Jørgen S.; Fairley, Christopher K.; Tabrizi, Sepehr N.;
    Published Date:
    May 2017
    Source:
    Emerg Infect Dis. 23(5):809-812.
    Description:
    Escalating resistance to azithromycin and moxifloxacin is being reported for Mycoplasma genitalium in the Asia-Pacific region. Analyzing 140 infections, we found pretreatment fluoroquinolone-resistance mutations in parC (13.6%) and gyrA (5%). ParC S8...
    File Type:
    Filetype[PDF - 9.10 MB]
  4. Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand
    Personal Author:
    Vesty, Anna; McAuliffe, Gary; Roberts, Sally; Henderson, Gillian; Basu, Indira;
    Published Date:
    Feb 2020
    Source:
    Emerg Infect Dis. 26(2):332-335
    Description:
    Our retrospective study compared genotypic antimicrobial resistance in Mycoplasma genitalium-positive specimens collected from 48 community and 33 sexual health clinic (SHC) patients. Macrolide resistance was similar in community (75%) and SHC (76%) ...
    File Type:
    Filetype[PDF - 507.65 KB]
  5. Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection
    Personal Author:
    Read, Tim R.H.; Jensen, Jørgen S.; Fairley, Christopher K.; Grant, Mieken; Danielewski, Jennifer A.; Su, Jenny; Murray, Gerald L.; Chow, Eric P.F.; Worthington, Karen; Garland, Suzanne M.; Tabrizi, Sepehr N.; Bradshaw, Catriona S.;
    Published Date:
    Feb 2018
    Source:
    Emerg Infect Dis. 24(2):328-335.
    Description:
    High levels of macrolide resistance and increasing fluoroquinolone resistance are found in Mycoplasma genitalium in many countries. We evaluated pristinamycin for macrolide-resistant M. genitalium in a sexual health center in Australia. Microbiologic...
    File Type:
    Filetype[PDF - 623.04 KB]